Epidemiology of heart failure with preserved ejection fraction

SM Dunlay, VL Roger, MM Redfield - Nature Reviews Cardiology, 2017 - nature.com
Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome associated
with poor quality of life, substantial health-care resource utilization, and premature mortality …

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College …

SM Al-Khatib, WG Stevenson, MJ Ackerman… - Journal of the American …, 2018 - jacc.org
The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone

JB Cohen, SJ Schrauben, L Zhao, MD Basso, ME Cvijic… - Heart failure, 2020 - jacc.org
Objectives This study sought to assess if clinical phenogroups differ in comprehensive
biomarker profiles, cardiac and arterial structure/function, and responses to spironolactone …

Calcium and excitation-contraction coupling in the heart

DA Eisner, JL Caldwell, K Kistamás… - Circulation …, 2017 - Am Heart Assoc
Cardiac contractility is regulated by changes in intracellular Ca concentration ([Ca2+] i).
Normal function requires that [Ca2+] i be sufficiently high in systole and low in diastole …

Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart …

O Chioncel, M Lainscak, PM Seferovic… - European journal of …, 2017 - Wiley Online Library
Aims The objectives of the present study were to describe epidemiology and outcomes in
ambulatory heart failure (HF) patients stratified by left ventricular ejection fraction (LVEF) and …

[PDF][PDF] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

P Ponikowski, AA Voors, SD Anker… - Kardiologia Polska …, 2016 - journals.viamedica.pl
5.2. 1. Ocena funkcji skurczowej lewej komory...................................... 1052 5.2. 2. Ocena
funkcji rozkurczowej lewej komory...................................... 1052 5.2. 3. Ocena funkcji prawej …

Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis

VS Hahn, LR Yanek, J Vaishnav, W Ying, D Vaidya… - Heart failure, 2020 - jacc.org
Objectives This study prospectively evaluated endomyocardial biopsies in patients with
heart failure with preserved ejection fraction (HFpEF) to identify histopathologic phenotypes …

Cost-of-illness studies in heart failure: a systematic review 2004–2016

W Lesyuk, C Kriza, P Kolominsky-Rabas - BMC cardiovascular disorders, 2018 - Springer
Background Heart failure is a major and growing medical and economic problem worldwide
as 1–2% of the healthcare budget are spent for heart failure. The prevalence of heart failure …

Heart failure drug treatment

P Rossignol, AF Hernandez, SD Solomon, F Zannad - The Lancet, 2019 - thelancet.com
Heart failure is the most common cardiovascular reason for hospital admission for people
older than 60 years of age. Few areas in medicine have progressed as remarkably as heart …

Epidemiology and aetiology of heart failure

B Ziaeian, GC Fonarow - Nature Reviews Cardiology, 2016 - nature.com
Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of>
37.7 million individuals globally. HF is a shared chronic phase of cardiac functional …